bih.button.backtotop.text

Bumrungrad Urology Center Certified by the Boston Scientific Institute (USA) for the Use of Hydrogel in Prostate Cancer Treatment

September 06, 2024

​Prostate cancer is common in older men and is likely to be increasingly common in Thailand as Thailand is a fully-fledged aging society.


Prostate cancer is common in older men and is likely to be increasingly common in Thailand as Thailand is a fully-fledged aging society. However, medical technology for diagnosing and treating prostate cancer continues to advance. In addition to more accurate diagnoses, modern technologies make treatment safer, reduces complications, and helps patients have a high quality of life post-treatment.

Bumrungrad International Hospital utilized hydrogel in the treatment of prostate cancer for the first time in Thailand in March of 2023. It is approved as safe by both the US FDA and Thailand’s Food and Drug Administration. Hydrogel can be absorbed and excreted by the body. Hydrogel is made of polyethylene glycol (PEG) and helps reduce the complications and side-effects of radiation therapy and brachytherapy.

Teerapon Amornvesukit, MD, Urology Specialist at Bumrungrad International Hospital, stated that the Bumrungrad Urology Center is a center of excellence with teams of highly experienced specialists and multidisciplinary teams. Currently, it treats over 1,500 cases of urinary tract cancer each year, of which approximately 300 are prostate cancer cases treated with radiation therapy. We are committed to continually bring in innovations and modern technologies to provide comprehensive specialized treatment--increasing treatment efficacy and improving the quality of life of our patients.


PRnews_HydrogelCertificate-20-(1).jpg

PRnews_HydrogelCertificate-19.jpg

PRnews_HydrogelCertificate-18.jpg

PRnews_HydrogelCertificate-17.jpg